-
平臺(tái)編號(hào)：bio-50294
-
國(guó)際編號(hào)：ATCC VR-2330
-
拉丁屬名： Fowlpox virus
-
規(guī)格：frozen
-
用途：ATCC原裝進(jìn)口
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu)
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫(kù)為準(zhǔn)）
中文名暫無*
ATCC? Number:VR-2330?
Classification: Poxviridae, Chordopoxvirinae, Avipoxvirus
Agent: Fowlpox virus deposited as Fowlpox virus, Avipoxvirus
Strain: FPV/MDVgBh [Recombinant vaccine for Marek's disease]
Depositors: K Nazerian
Biosafety Level:2
Shipped: frozen
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Host Organism : SL-29 chicken embryo fibroblasts (ATCCCRL-1590)
Incubation : Duration: 2-4 days at 37C, 5% CO2
Effect : Yes, in vitro effects: Cytopathic effects (typical poxvirus CPE, and plaque formation)
Comments : Recombinant vaccine for Marek's disesase in chicken contains glycoprotein B Homologue. The insert has the Lac Z marker, producing blue plaques in the presence of Blu-o-Gal in the agar.
References : 33406: Nazerian K, et al. Recombinant fowlpox vaccine for protection against Marek's disease. US Patent 5,369,025 dated Nov 29 1994
Classification: Poxviridae, Chordopoxvirinae, Avipoxvirus
Agent: Fowlpox virus deposited as Fowlpox virus, Avipoxvirus
Strain: FPV/MDVgBh [Recombinant vaccine for Marek's disease]
Depositors: K Nazerian
Biosafety Level:2
Shipped: frozen
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Host Organism : SL-29 chicken embryo fibroblasts (ATCCCRL-1590)
Incubation : Duration: 2-4 days at 37C, 5% CO2
Effect : Yes, in vitro effects: Cytopathic effects (typical poxvirus CPE, and plaque formation)
Comments : Recombinant vaccine for Marek's disesase in chicken contains glycoprotein B Homologue. The insert has the Lac Z marker, producing blue plaques in the presence of Blu-o-Gal in the agar.
References : 33406: Nazerian K, et al. Recombinant fowlpox vaccine for protection against Marek's disease. US Patent 5,369,025 dated Nov 29 1994
